Pliant Therapeutics, Inc.
PLRX
$1.38
-$0.09-6.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -219.52M | -210.30M | -201.68M | -185.41M | -170.74M |
| Total Depreciation and Amortization | 2.06M | 2.13M | 2.13M | 2.05M | 1.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.24M | 43.59M | 48.73M | 45.28M | 43.37M |
| Change in Net Operating Assets | 122.00K | 9.09M | 17.88M | 1.19M | 9.11M |
| Cash from Operations | -174.10M | -155.50M | -132.94M | -136.89M | -116.36M |
| Capital Expenditure | -2.62M | -3.85M | -3.70M | -2.90M | -2.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 152.53M | 144.19M | 136.83M | 143.32M | 108.99M |
| Cash from Investing | 149.91M | 140.34M | 133.13M | 140.42M | 106.74M |
| Total Debt Issued | 1.00K | 19.91M | 19.91M | 19.91M | 19.91M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.83M | 3.21M | 3.34M | 3.57M | 3.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -13.00K | -88.00K | -261.00K |
| Cash from Financing | 1.83M | 23.12M | 23.23M | 23.39M | 22.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.36M | 7.95M | 23.42M | 26.92M | 13.25M |